Pain Management and Opioids

To begin the course, please login or register by clicking ENROLL. After logging in, you will be able to complete the pretest and view the video/documents. You will have the option to complete the posttest, evaluation and receive credit. Some courses may have an associated cost.

Step Status
Pretest
Video/Document(s)
Posttest
Evaluation
Starts On: 1/1/2019: 12:00 AM
Ends On: 6/30/2019: 12:00 AM
Session Type: Internet Activity Enduring Material
Credits: 1
Description:

Faculty

Karl J. Haake, MD
Medical Director
Centene Corporation
Board Certified Anesthesiologist
Disclosures
Financial Relationships:
Other Relationships: Medtronic

Presenters should indicate if speaking off label. This activity originated as a presentation recorded on October 24, 2018, which was supported in part by The Centene Corporation.


Planning Committee
Justin Stubstad, Pharm.D., Juris Doctor - Centene Corporation
Financial Relationships: Nothing to disclose
Kristine Ziegler, RN Centene Corporation - VP, Clinical Programs & Strategy
Financial Relationships: Nothing to disclose
Carmin M Pruitt, RN, Certified Professional Coder Centene Corporation - Senior Director Clinical & Payment Policy & the Centralized Transplant Unit
Financial Relationships: Nothing to disclose
Objectives: The intended result of this activity is increased knowledge/competence, and upon completion of this course, participants should be able to:
  • Discuss how we arrived at the place of the opioid epidemic and where we are now, as well as the scope of the current problem
  • Clarify 2016 CDC Guidelines for Prescribing Opioids For Chronic Pain
  • Address the specific needs and how to address unmet needs for chronic pain patients
  • Delineate the significance of behavioral health for pain management
  • Recognize the stigma associated with opioid use disorder and have resources for speaking with patients
Additional Information:
Target Audience: This course is planned and designed interprofessionally by physicians, nurses and pharmacists. This course is designed for primary care physicians, pain management specialists, nurses, pharmacists, case managers and family practitioners.

Publication Date: January 1, 2019
Expiration Date: June 30, 2019

Accreditation Information:
wustlcme
In support of improving patient care, this activity has been planned and implemented by Centene Corporation and Washington University School of Medicine in St. Louis. Washington University School of Medicine in St Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Awarded for this Activity:
Credit Statement:
American Medical Association (AMA Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of 1 ANCC contact hours.
Accreditation Council for Pharmacy Education (ACPE)
This activity is approved for 1 contact hours (.1 CEUs) in states that recognize ACPE. Attending the full program will earn 1 contact hours (.1 CEUs). Unique Universal Activity Number JA0000340-9999-19-O12-H01-P. To be awarded credit, attendees must have participated in all sessions, complete the activity evaluation, and provide your NABP ePID number and date of birth.

References:
  • International Association for Institute of Medicine "Relieving Chronic Pain in America," 2011. International Association for the study of Pain
  • NCI. Pain (PDQ). www.nci.nih.gov/cancertopics/pdq/supportivecare/pain/HealthProfessional
  • https://www.cdc.gov/drugoverdose/pdf/Guidelines_Factsheet-a.pdf
Disclosure Information: It is the policy of Washington University School of Medicine in St. Louis, Continuing Medical Education, to ensure balance, independence, objectivity and scientific rigor in all its educational activities. All planners, faculty and other persons who may influence content of this CME activity have disclosed all relevant financial relationships with commercial interests. All disclosures have been reported and are indicated with their presentations. Any potential conflicts were addressed and resolved.

Presenters are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.

Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis. These presentations are not an endorsement of any commercial interests.

These presentations are the views and experiences of the presenters. The presenters' views do not represent the policy or position of Washington University School of Medicine in St. Louis. Washington University School of Medicine in St. Louis, Continuing Medical Education, is the provider for CME credits.
Category: Centene


Powered By AI 4.5